Malignant Neck Neoplasm — Trials

Malignant Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 607
Recruiting: 330
Ph III recruiting: 76
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: Sun Yat-sen University
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 501–550 of 771 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03630120	Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer	terminated	Phase 2	6	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Jul 14, 2021	clinicaltrials
NCT04955886	Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma	unknown	Phase 2	14	Fujian Cancer HospitalOTHER_GOV	1	Jul 9, 2021	clinicaltrials